Showing 1 - 8 results of 8 for search 'N. V. LOMAKIN', query time: 0.05s Refine Results
  1. 1
    EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME

    EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME by A. V. Rudakova, N. V. Lomakin

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:
  2. 2
    EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME

    EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME by A. V. Rudakova, N. V. Lomakin

    Published 2015
    Connect to this object online.
    Book
    Save to List
    Saved in:
  3. 3
    Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding

    Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding by A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin

    Published 2019
    Connect to this object online.
    Book
    Save to List
    Saved in:
  4. 4
    A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study

    A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Di... by N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  5. 5
    Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients

    Clinical Significance of Thrombin Blockade with Low Doses (2.5 mg) of Rivaroxaban in Ischemic Heart Disease Patients by A. B. Sumarokov, L. I. Buryachkovskaya, Y. V. Docenko, M. S. Kurochkin, N. V. Lomakin

    Published 2020
    Connect to this object online.
    Book
    Save to List
    Saved in:
  6. 6
    INDIVIDUAL APPROACH TO PATIENTS WITH INDICATION FOR ANTIPLATELET THERAPY. WHAT TO RELY ON IN CHOOSING THE THERAPY?

    INDIVIDUAL APPROACH TO PATIENTS WITH INDICATION FOR ANTIPLATELET THERAPY. WHAT TO RELY ON IN CHOOSING THE THERAPY? by N. V. LOMAKIN, A. B. SUMAROKOV, Yu. V. DOTSENKO, I. A. UCHITEL, L. I. BURYACHKOVSKAYA

    Published 2017
    Connect to this object online.
    Book
    Save to List
    Saved in:
  7. 7
    Sulodexide as pharmacotherapy for protection of endothelium and suppression of thrombosis in COVID-19

    Sulodexide as pharmacotherapy for protection of endothelium and suppression of thrombosis in COVID-19 by A. M. Melkumyants, L. I. Buryachkovskaya, N. V. Lomakin, O. A. Antonova, V. V. Ermiskin, Y. V. Dotsenko

    Published 2022
    Connect to this object online.
    Book
    Save to List
    Saved in:
  8. 8
    Experience of using Beers criteria in clinical practice (according to Russian literature)

    Experience of using Beers criteria in clinical practice (according to Russian literature) by M. S. Cherniaeva, M. A. Rozhkova, M. V. Kazakova, L. A. Egorova, O. M. Maslennikova, G. S. Lebedev, N. V. Lomakin, D. A. Sychev

    Published 2023
    Connect to this object online.
    Book
    Save to List
    Saved in:

Search Tools: